<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PIPERAZINE - Research Report</title>
    <meta name="description" content="Comprehensive naturopathic research report for PIPERAZINE">
    <style>
        
    * {
        box-sizing: border-box;
    }
    
    body {
        font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif;
        font-size: 16px;
        line-height: 1.6;
        margin: 0;
        padding: 0;
        background-color: #f8f9fa;
        color: #212529;
    }
    
    .container {
        max-width: 1200px;
        margin: 0 auto;
        padding: 20px;
        background-color: white;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }
    
    .medication-header {
        background: linear-gradient(135deg, #2c3e50, #003366);
        color: white;
        padding: 30px;
        margin: -20px -20px 30px -20px;
        border-radius: 0 0 10px 10px;
        text-align: center;
        position: relative;
    }
    
    .medication-header h1 {
        margin: 0 0 15px 0;
        font-size: 2.5em;
        font-weight: 600;
        text-shadow: 0 2px 4px rgba(0,0,0,0.3);
    }
    
    .status-badge {
        display: inline-block;
        padding: 8px 20px;
        border-radius: 25px;
        font-weight: 600;
        font-size: 0.9em;
        text-transform: uppercase;
        letter-spacing: 1px;
        box-shadow: 0 2px 4px rgba(0,0,0,0.2);
    }
    
    .status-allowed { background-color: #28a745; color: white; }
    .status-not-allowed { background-color: #dc3545; color: white; }
    .status-modernization { background-color: #fd7e14; color: white; }
    .status-topical { background-color: #20c997; color: white; }
    .status-review { background-color: #ffc107; color: #212529; }
    .status-not-applicable { background-color: #6c757d; color: white; }
    .status-unknown { background-color: #adb5bd; color: white; }
    
    .natural-connections {
        margin-bottom: 30px;
        padding: 20px;
        background-color: #f8f9fa;
        border-radius: 10px;
        border-left: 4px solid #007bff;
    }
    
    .natural-connections h2 {
        margin: 0 0 15px 0;
        font-size: 1.4em;
        color: #2c3e50;
    }
    
    .connection-tags {
        display: flex;
        flex-wrap: wrap;
        gap: 8px;
    }
    
    .connection-tag {
        display: inline-block;
        padding: 6px 12px;
        border-radius: 15px;
        font-size: 0.85em;
        font-weight: 500;
        color: white;
        white-space: nowrap;
    }
    
    .tag-direct { background-color: #0d6832; }
    .tag-semi-synthetic { background-color: #198754; }
    .tag-structural { background-color: #0d6efd; }
    .tag-endogenous { background-color: #6610f2; }
    .tag-biosynthetic { background-color: #6f42c1; }
    .tag-pathways { background-color: #0dcaf0; color: #212529; }
    .tag-processes { background-color: #3dd5f3; color: #212529; }
    
    .report-content {
        line-height: 1.7;
    }
    
    .report-content h1 {
        color: #2c3e50;
        border-bottom: 3px solid #007bff;
        padding-bottom: 10px;
        margin: 30px 0 20px 0;
    }
    
    .report-content h2 {
        color: #495057;
        border-bottom: 2px solid #dee2e6;
        padding-bottom: 8px;
        margin: 25px 0 15px 0;
    }
    
    .report-content h3 {
        color: #6c757d;
        margin: 20px 0 10px 0;
    }
    
    .report-content p {
        margin-bottom: 15px;
        text-align: justify;
    }
    
    .checkbox {
        font-weight: bold;
        margin-right: 5px;
    }
    
    .checkbox.checked { color: #28a745; }
    .checkbox.unchecked { color: #6c757d; }
    
    .footer {
        margin-top: 40px;
        padding: 20px 0;
        border-top: 1px solid #dee2e6;
        text-align: center;
        color: #6c757d;
        font-size: 0.9em;
    }
    
    .back-link {
        display: inline-block;
        margin-bottom: 20px;
        padding: 8px 16px;
        background-color: #007bff;
        color: white;
        text-decoration: none;
        border-radius: 5px;
        transition: background-color 0.3s;
    }
    
    .back-link:hover {
        background-color: #0056b3;
        text-decoration: none;
    }
    
    @media (max-width: 768px) {
        .container { 
            padding: 15px; 
            margin: 10px;
        }
        .medication-header { 
            margin: -15px -15px 20px -15px;
            padding: 20px;
        }
        .medication-header h1 { 
            font-size: 2em; 
        }
        .connection-tags {
            justify-content: center;
        }
    }
    
    @media print {
        .back-link { display: none; }
        .container { box-shadow: none; }
        .medication-header { 
            background: #2c3e50 !important;
            -webkit-print-color-adjust: exact;
        }
    }
    
    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">← Back to Index</a>
        
        <header class="medication-header">
            <h1>PIPERAZINE</h1>
            <div class="status-badge status-allowed">
                ALLOWED
            </div>
        </header>
        
        <section class="natural-connections">
            <h2>Natural Connections</h2>
            <div class="connection-tags">
                <span class="connection-tag tag-pathways">Works Natural Pathways</span>
<span class="connection-tag tag-processes">Facilitates Natural Processes</span>

            </div>
        </section>
        
        <main class="report-content">
            <h2>1. NATURAL DERIVATION ASSESSMENT</h2>
<h3>Source Investigation</h3>
PIPERAZINE works through naturally occurring biological pathways and receptor systems. No documentation exists for natural occurrence in plants, animals, fungi, minerals, or marine organisms. The compound is not produced through fermentation or biosynthetic methods from natural sources. Historically, piperazine has been manufactured through synthetic chemical processes involving the reaction of ethylene glycol with ammonia or through cyclization of diethylene glycol diamine.
<h3>Structural Analysis</h3>
Piperazine (C₄H₁₀N₂) is a heterocyclic organic compound containing a six-membered ring with two nitrogen atoms in opposite positions. While the piperazine ring system does not occur naturally as a free compound, piperazine-containing structures are found in some natural products, including certain alkaloids and peptides. The basic nitrogen atoms in piperazine can form hydrogen bonds similar to those in naturally occurring diamines and some amino acid derivatives.
<h3>Biological Mechanism Evaluation</h3>
Piperazine functions as an anthelmintic (anti-parasitic) agent by acting as a GABA (gamma-aminobutyric acid) receptor agonist in parasitic nematodes. This mechanism causes flaccid paralysis of the parasite&#x27;s musculature by blocking neuromuscular transmission. GABA is a naturally occurring inhibitory neurotransmitter in both human and invertebrate nervous systems, representing an evolutionarily conserved signaling pathway.
<h3>Natural System Integration (Expanded Assessment)</h3>
Piperazine targets naturally occurring GABA receptors, which are evolutionarily conserved across species but with structural differences between mammals and parasites that allow for selective toxicity. The medication works within established neurotransmitter pathways and removes obstacles to natural healing by eliminating parasitic infections that disrupt normal physiological function. The compound enables the body&#x27;s natural immune and digestive systems to return to homeostatic balance by eliminating parasitic burdens. It provides a targeted intervention that can prevent the need for more invasive treatments or chronic parasitic infections.
<h2>2. THERAPEUTIC CONTEXT</h2>
<h3>Mechanism of Action</h3>
Piperazine acts as a GABA receptor agonist specifically in parasitic nematodes, causing hyperpolarization of nerve membranes and resulting in flaccid paralysis. This selective action occurs because mammalian and nematode GABA receptors have different structural characteristics, allowing piperazine to preferentially affect parasite nervous systems while having minimal impact on human GABA receptors at therapeutic doses.
<h3>Clinical Utility</h3>
Primary therapeutic applications include treatment of roundworm (Ascaris lumbricoides) and pinworm (Enterobius vermicularis) infections. Piperazine has been used for decades as a first-line anthelmintic, particularly in pediatric populations due to its relatively favorable safety profile. It is typically used as a short-term treatment (1-3 days) rather than for chronic administration. The medication has largely been superseded by newer anthelmintics like albendazole and mebendazole in many regions.
<h3>Integration Potential</h3>
Piperazine can be integrated into comprehensive naturopathic treatment protocols for parasitic infections, potentially combined with supportive therapies such as probiotics, digestive enzymes, and immune-supporting botanicals. The medication creates a therapeutic window by rapidly eliminating parasites, allowing natural healing processes and gut microbiome restoration to proceed. Practitioner education regarding proper dosing, contraindications, and monitoring for treatment efficacy would be required.
<h2>3. REGULATORY AND PRECEDENT CONTEXT</h2>
<h3>Current Status</h3>
Piperazine was previously approved by the FDA for human use but is no longer available as a prescription medication in the United States, having been withdrawn due to market factors rather than safety concerns. It remains available in some over-the-counter preparations and is still used in veterinary medicine. The compound is included in the WHO Model List of Essential Medicines for treatment of ascariasis and enterobiasis.
<h3>Comparable Medications</h3>
Other anthelmintic medications with different mechanisms of action are included in various formularies, including albendazole and mebendazole (benzimidazole derivatives) and ivermectin (avermectin derivative). These medications share the therapeutic goal of parasite elimination while working through different molecular targets.
<h2>4. EVIDENCE DOCUMENTATION</h2>
<h3>Primary Sources Consulted</h3>
Literature review focused on piperazine&#x27;s mechanism of action, natural system interactions, GABA receptor pharmacology, anthelmintic efficacy, and safety profile. Sources included pharmaceutical databases, peer-reviewed research on GABA receptors, WHO essential medicines documentation, and historical pharmacological literature.
<h3>Key Findings</h3>
Evidence demonstrates that piperazine targets evolutionarily conserved GABA receptor systems with selective activity against parasitic nematodes. The compound integrates with natural neurotransmitter pathways and facilitates restoration of normal physiological function by eliminating parasitic infections. Safety data supports short-term use with minimal systemic toxicity in humans.
<h2>5. COMPREHENSIVE ASSESSMENT</h2>
<p><strong>PIPERAZINE</strong></p>
<p><strong>Evidence Categories Present:</strong><br><span class="checkbox unchecked">☐</span> Direct natural source<br><span class="checkbox unchecked">☐</span> Semi-synthetic from natural precursor<br><span class="checkbox unchecked">☐</span> Structural analog of natural compound<br><span class="checkbox unchecked">☐</span> Endogenous compound or replacement<br><span class="checkbox unchecked">☐</span> Biosynthetic/fermentation product<br><span class="checkbox checked">✓</span> Works through natural pathways/receptors<br><span class="checkbox checked">✓</span> Facilitates natural physiological processes<br><span class="checkbox unchecked">☐</span> No identified natural connection</p>
<p><strong>Natural Derivation Assessment:</strong><br>Piperazine is a laboratory-produced compound with no direct natural sources identified. However, it demonstrates significant integration with natural biological systems through its interaction with evolutionarily conserved GABA receptor pathways.</p>
<p><strong>Structural/Functional Relationships:</strong><br>While piperazine itself is not naturally occurring, the piperazine ring system appears in some natural alkaloids and peptides. The compound&#x27;s diamine structure allows for hydrogen bonding patterns similar to those found in naturally occurring diamines.</p>
<p><strong>Biological Integration:</strong><br>Piperazine functions through GABA receptor systems that are naturally occurring and evolutionarily conserved. The medication&#x27;s mechanism relies on existing neurotransmitter pathways, demonstrating integration with natural biological systems despite its synthetic origin.</p>
<p><strong>Natural System Interface:</strong><br>The medication works within naturally occurring GABA neurotransmitter systems, utilizing evolutionarily conserved receptors with selective targeting of parasitic organisms. Piperazine enables restoration of natural physiological balance by eliminating parasitic infections that disrupt normal digestive, immune, and metabolic functions.</p>
<p><strong>Safety and Therapeutic Profile:</strong><br>Generally well-tolerated with short-term use. Side effects are typically mild and include gastrointestinal upset, dizziness, and rarely neurological symptoms. Contraindicated in patients with seizure disorders or severe renal impairment. Represents a less invasive alternative to surgical intervention for severe parasitic infections.</p>
<p><strong>Documentation Quality:</strong><br>- Number of sources confirming natural connection: 0<br>- Number of sources documenting system integration: 4<br>- Strength of evidence: Documented<br>- Conflicting information noted: No</p>
<p><strong>Summary of Findings:</strong><br>Piperazine is a synthetic anthelmintic compound that, while not derived from natural sources, demonstrates significant integration with natural biological systems through its interaction with evolutionarily conserved GABA receptor pathways. The medication facilitates restoration of natural physiological processes by eliminating parasitic infections that disrupt normal bodily functions.</p>
<p><strong>Relevant Citations:</strong></p>
<p>1. DrugBank. &quot;Piperazine&quot; DrugBank Accession Number DB00592. University of Alberta, updated 2024.</p>
<p>2. World Health Organization. &quot;WHO Model List of Essential Medicines, 23rd List.&quot; Geneva: World Health Organization; 2023. Section 6.1.1 Intestinal anthelminthics.</p>
<p>3. Martin RJ. &quot;Modes of action of anthelmintic drugs.&quot; Veterinary Journal. 1997;154(1):11-34.</p>
<p>4. Saz HJ, Weil A. &quot;The mechanism of the neuromuscular blocking action of piperazine on Ascaris muscle.&quot; Journal of Pharmacology and Experimental Therapeutics. 1960;130:112-117.</p>
<p>5. PubChem. &quot;Piperazine&quot; PubChem CID 4837. National Center for Biotechnology Information, National Library of Medicine.</p>
<p>6. Holden-Dye L, Walker RJ. &quot;Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.&quot; WormBook. 2014 Jan 3:1-29.</p>
        </main>
        
        <footer class="footer">
            <p>Generated on September 12, 2025 at 12:39 PM</p>
        </footer>
    </div>
</body>
</html>